Ivermectin: Panacea or true promise for COVID-19

Authors

  • Luana Heimfarth Laboratory of Neuroscience and Pharmacological Assays (LANEF), Department of Physiology, Federal University of Sergipe-UFS, Av. Marechal Rondom, s/n, São Cristóvão, Sergipe-Brazil. Zip Code: 49.100-000. Tel.: +55-79-21056645; Fax: +55-79-3212-6640; E-mail: luahei@yahoo.com.br https://orcid.org/0000-0002-4503-8905
  • Victor Santana Santos Centre for Epidemiology and Public Health, Federal University of Alagoas, Arapiraca, Brazil https://orcid.org/0000-0003-0194-7397
  • Adriano Antunes de Souza Araújo Department of Pharmacy, Federal University of Sergipe, São Cristóvão, Brazil https://orcid.org/0000-0001-9665-9923
  • Lucindo José Quintans-Júnior Laboratory of Neuroscience and Pharmacological Assays (LANEF), Federal University of Sergipe, São Cristóvão, Brazil https://orcid.org/0000-0001-5155-938X
  • Paulo Ricardo Martins-Filho Investigative Pathology Laboratory, Federal University of Sergipe, Aracaju, Brazil https://orcid.org/0000-0001-8779-0727

DOI:

https://doi.org/10.17179/excli2020-3022

Keywords:

SARS-CoV-2, ivermectin , drug

Published

2020-11-09

How to Cite

Heimfarth, L., Santos, V. S. ., Araújo, A. A. de S. ., Quintans-Júnior, L. J. ., & Martins-Filho, P. R. . (2020). Ivermectin: Panacea or true promise for COVID-19. EXCLI Journal, 19, 1517–1519. https://doi.org/10.17179/excli2020-3022

Issue

Section

Letters to the editor

Most read articles by the same author(s)

<< < 1 2